VBI Vaccines
VBIV
#10522
Rank
HK$14.59 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.29%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$79.02. In 2022 the company made an earnings per share (EPS) of -HK$102.87 a decrease over its 2021 EPS that were of -HK$63.12.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$102.8762.96%
2021-HK$63.1228.57%
2020-HK$49.10-54.35%
2019-HK$107.54-52.58%
2018-HK$226.7810.23%
2017-HK$205.7414.29%
2016-HK$180.02-62.8%
2015-HK$483.9590.68%
2014-HK$253.81-7.95%
2013-HK$275.74-57.97%
2012-HK$656.12-78%
2011-HK$2,9833151.47%
2010-HK$91.7423.87%
2009-HK$74.06-18.48%
2008-HK$90.8612.08%
2007-HK$81.07-49.47%
2006-HK$160.43
2005N/A-100%
2004-HK$71.3211.94%
2003-HK$63.71-81.89%
2002-HK$351.81196.44%
2001-HK$118.6884.33%
2000-HK$64.38-65.37%
1999-HK$185.92-29.45%
1998-HK$263.5229.61%
1997-HK$203.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.40-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.74-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.60-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA